Mclean, Chelsea.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Mclean, Chelsea.Pdf COMPUTATIONAL PREDICTION AND EXPERIMENTAL VALIDATION OF NOVEL MOUSE IMPRINTED GENES A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Chelsea Marie McLean August 2009 © 2009 Chelsea Marie McLean COMPUTATIONAL PREDICTION AND EXPERIMENTAL VALIDATION OF NOVEL MOUSE IMPRINTED GENES Chelsea Marie McLean, Ph.D. Cornell University 2009 Epigenetic modifications, including DNA methylation and covalent modifications to histone tails, are major contributors to the regulation of gene expression. These changes are reversible, yet can be stably inherited, and may last for multiple generations without change to the underlying DNA sequence. Genomic imprinting results in expression from one of the two parental alleles and is one example of epigenetic control of gene expression. So far, 60 to 100 imprinted genes have been identified in the human and mouse genomes, respectively. Identification of additional imprinted genes has become increasingly important with the realization that imprinting defects are associated with complex disorders ranging from obesity to diabetes and behavioral disorders. Despite the importance imprinted genes play in human health, few studies have undertaken genome-wide searches for new imprinted genes. These have used empirical approaches, with some success. However, computational prediction of novel imprinted genes has recently come to the forefront. I have developed generalized linear models using data on a variety of sequence and epigenetic features within a training set of known imprinted genes. The resulting models were used to predict novel imprinted genes in the mouse genome. After imposing a stringency threshold, I compiled an initial candidate list of 155 genes. A subset of these genes was tested for evidence of imprinting using allele-specific restriction digests in either brain or placenta. Of the 10 genes tested in placenta, 2 showed evidence of maternal allele-specific expression. I also designed a custom microarray to test a total of 563 genes predicted as imprinted at lower stringency levels. Of these 563 genes, I experimentally tested 32 in placenta and 8 in brain, resulting in the identification of an additional 5 novel imprinted genes in placenta. This study is the first to demonstrate the utility of epigenetic marks in the prediction of imprinted genes. Furthermore, specific combinations of epigenetic marks were commonly found within particular regions relative to the transcriptional start sites of imprinted genes, implicating their placement and localization in the imprinting mechanism. BIOGRAPHICAL SKETCH Chelsea McLean was born on June 19, 1982 in Rochester, Michigan to Dara and Larry McLean. She graduated from Rochester Adams High School in 2000, where she took part in two field courses: Tropical Rainforest Ecology and Coral Reef Biology in Belize, Central America and The Ecology of Greater Yellowstone National Park in Yellowstone National Park. She credits participation in these courses for a large part of her interest in science. After high school, she continued on to the Lyman Briggs School at Michigan State University in East Lansing, Michigan. While at Michigan State, she participated in a wide variety of service organizations and taught two Honors level Biology labs: Lyman Briggs Honors Organismal Biology Lab, under the direction of Dr. Charles Elzinga, and Lyman Briggs Honors Cell and Molecular Biology Lab, under the direction of Dr. John Urbance. She also conducted research for two years in the Canine Genetics Lab of Dr. Patrick Venta and for one summer in the Small Fruit Entomology Lab of Dr. Rufus Isaacs. In 2004, Chelsea graduated with High Honor and a Bachelor of Science degree in Microbiology and Molecular Genetics and was recognized as a Michigan State University Outstanding Senior. After graduation, she moved to Ithaca, New York to attend graduate school at Cornell University and to pursue a Ph.D. in Genetics and Development under the instruction of Dr. Paul Soloway. Upon completion of her dissertation in 2009, Chelsea continued on to a postdoctoral position in the lab of Drs. Elizabeth Robertson and Elizabeth Bikoff at the University of Oxford in Oxford, U.K. iii To my family, Dara, Larry, and Danielle: for your love and support. And for always telling me that I can do anything I set my mind to. To my teachers: Todd Vince and Dave Glenn for sharing your enthusiasm for science and for being wonderful teachers. To my best friend: Nick Brideau for always being there for me. To all of my friends: For making my time in Ithaca memorable and enjoyable. iv ACKNOWLEDGMENTS There are so many people I have to acknowledge for their help, guidance, and friendship while I was at Cornell. Without these people, I would not be where I am today. First, my advisor, Paul Soloway, for his support over the last five years. From him, I learned countless scientific techniques, as well as how to think both critically and creatively. Also, the members of my special committee for their guidance throughout the many difficult phases of my various Ph.D. projects: Dr. Andrew Clark, Dr. John Schimenti, and Dr. Tudorita Tumbar. And, along the way, I was lucky to have some wonderful labmates, who taught me so much through example and through discussion. Rebecca Holmes, Anders Lindroth, and Yoon Jung Park were an invaluable part of my experience at Cornell, as was Herry Herman, who was my mentor during my rotation in the Soloway lab. And, of course Patrick Murphy for his sunny disposition and his unbridaled enthusiasm for science, Ruquian Zhao for her support, encouragememt, and phoenix good luck charm. Jim Putnam for his ever-sunny attitude and for keeping our lab running smoothly. And, of course, my friends. Karen Osorio for always listening, for making me laugh, and for her amazing desserts. Rebecca Holmes and Nathalie Nicod, who were there with me everyday and provided (decaf) coffee breaks, laughter, chocolate, and encouragement as needed. Sam and David Infanger for beautiful days on Ms. Green and fun nights of creative social events. Kim Holloway for her endless cheer, great barbecue, and love of good v fish and chips…with or without mushy peas. Amanda Larracuente for our fun dinners out and Bluestone Mojitos. And, of course, “The Girls” for our girls’ nights. I also have to thank my very best friend and future husband, Nick Brideau. Without him, I could not have made it through everything that happened to me while I was in Ithaca, both personally and professionally. Without his love and support, I quite literally would not be writing this dissertation. Finally, I would like to acknowledge my family. It is because of them that I learned the value of education and organization. From as far back as I can remember, my family managed to combine education and fun. For this I am grateful, as I never viewed education as a chore, but as a privelage. Also, because of the various after school activities that I was involved in, I learned how to multi-task and to complete projects under a deadline. I couldn’t have learned these skills without dedicated parents who not only shuttled me to and from my various activities on time, but also made sure my homework was complete at the end of each day. Even now, from across the country, my family manages to provide their unconditional support, for which I am extremely grateful, and I can only hope that I have made them proud. vi TABLE OF CONTENTS BIOGRAPHICAL SKETCH........................................................................... iii DEDICATION............................................................................................... iv ACKNOWLEDGMENTS .............................................................................. v TABLE OF CONTENTS............................................................................... vii LIST OF FIGURES ...................................................................................... xi LIST OF TABLES......................................................................................... xv LIST OF ABBREVIATIONS ......................................................................... xvi LIST OF SYMBOLS..................................................................................... xix I. INTRODUCTION I.1 Epigenetic regulation of gene expression ............................................ 1 I.1.1 Introduction to epigenetics ............................................................ 1 I.1.2 DNA methylation........................................................................... 2 I.1.3 Histone modifications.................................................................... 4 I.2 Genomic imprinting.............................................................................. 5 I.2.I Introduction to genomic imprinting .................................................. 5 I.2.2 History of genomic imprinting......................................................... 7 I.2.3 DNA methylation and genomic imprinting ...................................... 8 I.2.4 Histone modifications and genomic imprinting............................... 12 I.3 Epigenetics in development and disease............................................. 14 I.3.1 Developmental timing of methylation marks .................................. 14 I.3.2 Trans-acting DNA methylation reprogramming factors .................. 15 I.3.3 Cis-acting DNA methylation reprogramming factors ...................... 17 I.3.4 Causes and consequences
Recommended publications
  • Analyses of Allele-Specific Gene Expression in Highly Divergent
    ARTICLES Analyses of allele-specific gene expression in highly divergent mouse crosses identifies pervasive allelic imbalance James J Crowley1,10, Vasyl Zhabotynsky1,10, Wei Sun1,2,10, Shunping Huang3, Isa Kemal Pakatci3, Yunjung Kim1, Jeremy R Wang3, Andrew P Morgan1,4,5, John D Calaway1,4,5, David L Aylor1,9, Zaining Yun1, Timothy A Bell1,4,5, Ryan J Buus1,4,5, Mark E Calaway1,4,5, John P Didion1,4,5, Terry J Gooch1,4,5, Stephanie D Hansen1,4,5, Nashiya N Robinson1,4,5, Ginger D Shaw1,4,5, Jason S Spence1, Corey R Quackenbush1, Cordelia J Barrick1, Randal J Nonneman1, Kyungsu Kim2, James Xenakis2, Yuying Xie1, William Valdar1,4, Alan B Lenarcic1, Wei Wang3,9, Catherine E Welsh3, Chen-Ping Fu3, Zhaojun Zhang3, James Holt3, Zhishan Guo3, David W Threadgill6, Lisa M Tarantino7, Darla R Miller1,4,5, Fei Zou2,11, Leonard McMillan3,11, Patrick F Sullivan1,5,7,8,11 & Fernando Pardo-Manuel de Villena1,4,5,11 Complex human traits are influenced by variation in regulatory DNA through mechanisms that are not fully understood. Because regulatory elements are conserved between humans and mice, a thorough annotation of cis regulatory variants in mice could aid in further characterizing these mechanisms. Here we provide a detailed portrait of mouse gene expression across multiple tissues in a three-way diallel. Greater than 80% of mouse genes have cis regulatory variation. Effects from these variants influence complex traits and usually extend to the human ortholog. Further, we estimate that at least one in every thousand SNPs creates a cis regulatory effect.
    [Show full text]
  • Aberrant Methylation Underlies Insulin Gene Expression in Human Insulinoma
    ARTICLE https://doi.org/10.1038/s41467-020-18839-1 OPEN Aberrant methylation underlies insulin gene expression in human insulinoma Esra Karakose1,6, Huan Wang 2,6, William Inabnet1, Rajesh V. Thakker 3, Steven Libutti4, Gustavo Fernandez-Ranvier 1, Hyunsuk Suh1, Mark Stevenson 3, Yayoi Kinoshita1, Michael Donovan1, Yevgeniy Antipin1,2, Yan Li5, Xiaoxiao Liu 5, Fulai Jin 5, Peng Wang 1, Andrew Uzilov 1,2, ✉ Carmen Argmann 1, Eric E. Schadt 1,2, Andrew F. Stewart 1,7 , Donald K. Scott 1,7 & Luca Lambertini 1,6 1234567890():,; Human insulinomas are rare, benign, slowly proliferating, insulin-producing beta cell tumors that provide a molecular “recipe” or “roadmap” for pathways that control human beta cell regeneration. An earlier study revealed abnormal methylation in the imprinted p15.5-p15.4 region of chromosome 11, known to be abnormally methylated in another disorder of expanded beta cell mass and function: the focal variant of congenital hyperinsulinism. Here, we compare deep DNA methylome sequencing on 19 human insulinomas, and five sets of normal beta cells. We find a remarkably consistent, abnormal methylation pattern in insu- linomas. The findings suggest that abnormal insulin (INS) promoter methylation and altered transcription factor expression create alternative drivers of INS expression, replacing cano- nical PDX1-driven beta cell specification with a pathological, looping, distal enhancer-based form of transcriptional regulation. Finally, NFaT transcription factors, rather than the cano- nical PDX1 enhancer complex, are predicted to drive INS transactivation. 1 From the Diabetes Obesity and Metabolism Institute, The Department of Surgery, The Department of Pathology, The Department of Genetics and Genomics Sciences and The Institute for Genomics and Multiscale Biology, The Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
    [Show full text]
  • BIOINFORMATICS Pages 1–7
    Vol. 00 no. 00 2010 BIOINFORMATICS Pages 1–7 Integrative classification and analysis of multiple arrayCGH datasets with probe alignment Ze Tian and Rui Kuang∗ Department of Computer Science and Engineering, University of Minnesota Twin Cities, Minneapolis, USA Received on XXXXX; revised on XXXXX; accepted on XXXXX Associate Editor: XXXXXXX ABSTRACT 2009). Chromosome copy number variations can be measured by Motivation: Array comparative genomic hybridization (ArrayCGH) comparative genomic hybridization (CGH), which compares the is widely used to measure DNA copy numbers in cancer research. copy number of a differentially labeled case sample with a reference ArrayCGH data report log-ratio intensities of thousands of probes DNA from a normal individual. ArrayCGH technology based on sampled along the chromosomes. Typically, the choices of the DNA microarray can currently allow genome-wide identification locations and the lengths of the probes vary in different experiments. of regions with copy number variations at different resolutions This discrepancy in choosing probes poses a challenge in integrated (Carter, 2007). The arrayCGH data was used to discriminate healthy classification or analysis across multiple arrayCGH datasets. We patients from cancer patients and classify patients of different cancer propose an alignment based framework to integrate arrayCGH subtypes. Thus, arrayCGH data is considered as a new source of samples generated from different probe sets. The alignment biomarkers that provide important information of candidate cancer framework seeks an optimal alignment between the probe series loci for the classification of patients and discovery of molecular of one arrayCGH sample and the probe series of another sample, mechanisms of cancers (Sykes et al., 2009).
    [Show full text]
  • Investigating the Genetic Basis of Cisplatin-Induced Ototoxicity in Adult South African Patients
    --------------------------------------------------------------------------- Investigating the genetic basis of cisplatin-induced ototoxicity in adult South African patients --------------------------------------------------------------------------- by Timothy Francis Spracklen SPRTIM002 SUBMITTED TO THE UNIVERSITY OF CAPE TOWN In fulfilment of the requirements for the degree MSc(Med) Faculty of Health Sciences UNIVERSITY OF CAPE TOWN University18 December of Cape 2015 Town Supervisor: Prof. Rajkumar S Ramesar Co-supervisor: Ms A Alvera Vorster Division of Human Genetics, Department of Pathology, University of Cape Town 1 The copyright of this thesis vests in the author. No quotation from it or information derived from it is to be published without full acknowledgement of the source. The thesis is to be used for private study or non- commercial research purposes only. Published by the University of Cape Town (UCT) in terms of the non-exclusive license granted to UCT by the author. University of Cape Town Declaration I, Timothy Spracklen, hereby declare that the work on which this dissertation/thesis is based is my original work (except where acknowledgements indicate otherwise) and that neither the whole work nor any part of it has been, is being, or is to be submitted for another degree in this or any other university. I empower the university to reproduce for the purpose of research either the whole or any portion of the contents in any manner whatsoever. Signature: Date: 18 December 2015 ' 2 Contents Abbreviations ………………………………………………………………………………….. 1 List of figures …………………………………………………………………………………... 6 List of tables ………………………………………………………………………………….... 7 Abstract ………………………………………………………………………………………… 10 1. Introduction …………………………………………………………………………………. 11 1.1 Cancer …………………………………………………………………………….. 11 1.2 Adverse drug reactions ………………………………………………………….. 12 1.3 Cisplatin …………………………………………………………………………… 12 1.3.1 Cisplatin’s mechanism of action ……………………………………………… 13 1.3.2 Adverse reactions to cisplatin therapy ……………………………………….
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2005/0010974A1 Milligan Et Al
    US 20050010974A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2005/0010974A1 Milligan et al. (43) Pub. Date: Jan. 13, 2005 (54) PROMOTERS FOR REGULATION OF GENE Publication Classification EXPRESSION IN PLANT ROOTS (51) Int. Cl." ............................ C12N 15/82; C12O 1/68; (76) Inventors: Stephen B Milligan, Kirkland, WA C12N 15/87; C12N 15/63; (US); Dale Skalla, Research Triangle C12N 15/85; C12N 5/10; Park, NC (US); Kay Lawton, Research C12N 15/09; CO7H 21/04 Triangle Park, NC (US) (52) U.S. Cl. ..................... 800/287; 536/23.6; 435/320.1; 435/455; 435/419; 435/468; Correspondence Address: 800/278; 435/6; 536/24.33 Randee S Schwatz Syngenta Biotechnology 3054 Cornwallis Road (57) ABSTRACT Research Triangle Park, NC 27709 (US) The present invention is directed to promoters isolated from (21) Appl. No.: 10/490,147 maize and functional equivalents thereto. The promoters of the present invention have particular utility in driving root (22) PCT Filed: Nov. 4, 2002 Specific expression of heterologous genes that impart (86) PCT No.: PCT/US02/35374 increased agronomic, horticultural and/or pesticidal charac teristics to a given promoters of the invention and trans (30) Foreign Application Priority Data formed plant tissues containing DNA molecules comprising a promoter of the invention operably linked to a heterolo Nov. 7, 2001 (US)........................................... 60337026 gous gene or genes, and Seeds thereof. US 2005/0010974 A1 Jan. 13, 2005 PROMOTERS FOR REGULATION OF GENE latory Sequences may be short regions of DNA sequence EXPRESSION IN PLANT ROOTS 6-100 base pairs that define the binding sites for trans-acting factors, Such as transcription factors.
    [Show full text]
  • Downloaded and Searched Against the Dbest Database to Identify Ests
    BMC Genomics BioMed Central Research article Open Access A transcription map of the 6p22.3 reading disability locus identifying candidate genes Eric R Londin1, Haiying Meng2 and Jeffrey R Gruen*2 Address: 1Graduate Program in Genetics, State University of New York at Stony Brook, NY, USA and 2Yale Child Health Research Center, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA Email: Eric R Londin - [email protected]; Haiying Meng - [email protected]; Jeffrey R Gruen* - [email protected] * Corresponding author Published: 30 June 2003 Received: 22 April 2003 Accepted: 30 June 2003 BMC Genomics 2003, 4:25 This article is available from: http://www.biomedcentral.com/1471-2164/4/25 © 2003 Londin et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. reading disabilitydyslexia6p22.3In silicoESTs Abstract Background: Reading disability (RD) is a common syndrome with a large genetic component. Chromosome 6 has been identified in several linkage studies as playing a significant role. A more recent study identified a peak of transmission disequilibrium to marker JA04 (G72384) on chromosome 6p22.3, suggesting that a gene is located near this marker. Results: In silico cloning was used to identify possible candidate genes located near the JA04 marker. The 2 million base pairs of sequence surrounding JA04 was downloaded and searched against the dbEST database to identify ESTs. In total, 623 ESTs from 80 different tissues were identified and assembled into 153 putative coding regions from 19 genes and 2 pseudogenes encoded near JA04.
    [Show full text]
  • Research Article Characterization, Tissue Expression, and Imprinting Analysis of the Porcine CDKN1C and NAP1L4 Genes
    Hindawi Publishing Corporation Journal of Biomedicine and Biotechnology Volume 2012, Article ID 946527, 7 pages doi:10.1155/2012/946527 Research Article Characterization, Tissue Expression, and Imprinting Analysis of the Porcine CDKN1C and NAP1L4 Genes Shun Li,1 Juan Li,1 Jiawei Tian,1 Ranran Dong,1 Jin Wei,1 Xiaoyan Qiu,2 and Caode Jiang2 1 School of Life Science, Southwest University, Chongqing 400715, China 2 College of Animal Science and Technology, Southwest University, Chongqing 400715, China Correspondence should be addressed to Caode Jiang, [email protected] Received 4 August 2011; Revised 25 October 2011; Accepted 15 November 2011 Academic Editor: Andre Van Wijnen Copyright © 2012 Shun Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CDKN1C and NAP1L4 in human CDKN1C/KCNQ1OT1 imprinted domain are two key candidate genes responsible for BWS (Beckwith-Wiedemann syndrome) and cancer. In order to increase understanding of these genes in pigs, their cDNAs are characterized in this paper. By the IMpRH panel, porcine CDKN1C and NAP1L4 genes were assigned to porcine chromosome 2, closely linked with IMpRH06175 and with LOD of 15.78 and 17.94, respectively. By real-time quantitative RT-PCR and polymorphism-based method, tissue and allelic expression of both genes were determined using F1 pigs of Rongchang and Landrace reciprocal crosses. The transcription levels of porcine CDKN1C and NAP1L4 were significantly higher in placenta than in other neonatal tissues (P<0.01) although both genes showed the highest expression levels in the lung and kidney of one- month pigs (P<0.01).
    [Show full text]
  • Protein Identities in Evs Isolated from U87-MG GBM Cells As Determined by NG LC-MS/MS
    Protein identities in EVs isolated from U87-MG GBM cells as determined by NG LC-MS/MS. No. Accession Description Σ Coverage Σ# Proteins Σ# Unique Peptides Σ# Peptides Σ# PSMs # AAs MW [kDa] calc. pI 1 A8MS94 Putative golgin subfamily A member 2-like protein 5 OS=Homo sapiens PE=5 SV=2 - [GG2L5_HUMAN] 100 1 1 7 88 110 12,03704523 5,681152344 2 P60660 Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6 PE=1 SV=2 - [MYL6_HUMAN] 100 3 5 17 173 151 16,91913397 4,652832031 3 Q6ZYL4 General transcription factor IIH subunit 5 OS=Homo sapiens GN=GTF2H5 PE=1 SV=1 - [TF2H5_HUMAN] 98,59 1 1 4 13 71 8,048185945 4,652832031 4 P60709 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 - [ACTB_HUMAN] 97,6 5 5 35 917 375 41,70973209 5,478027344 5 P13489 Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 - [RINI_HUMAN] 96,75 1 12 37 173 461 49,94108966 4,817871094 6 P09382 Galectin-1 OS=Homo sapiens GN=LGALS1 PE=1 SV=2 - [LEG1_HUMAN] 96,3 1 7 14 283 135 14,70620005 5,503417969 7 P60174 Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 - [TPIS_HUMAN] 95,1 3 16 25 375 286 30,77169764 5,922363281 8 P04406 Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 - [G3P_HUMAN] 94,63 2 13 31 509 335 36,03039959 8,455566406 9 Q15185 Prostaglandin E synthase 3 OS=Homo sapiens GN=PTGES3 PE=1 SV=1 - [TEBP_HUMAN] 93,13 1 5 12 74 160 18,68541938 4,538574219 10 P09417 Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 - [DHPR_HUMAN] 93,03 1 1 17 69 244 25,77302971 7,371582031 11 P01911 HLA class II histocompatibility antigen,
    [Show full text]
  • Integrative Analyses Identify Potential Key Genes and Pathways in Keshan
    medRxiv preprint doi: https://doi.org/10.1101/2021.03.12.21253491; this version posted March 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Integrative analyses identify potential key genes and pathways in Keshan disease using whole-exome sequencing Jichang Huang1#, Chenqing Zheng2#, Rong Luo1#, Mingjiang Liu3, Qingquan Gu4, Jinshu Li5, Xiushan Wu6, Zhenglin Yang3, Xia Shen2*, Xiaoping Li3* 1 Institute of Geriatric Cardiovascular Disease, Chengdu Medical College, Chengdu, People’s Republic of China 2 State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China 3 Department of Cardiology, Hospital of the University of Electronic Science and Technology of China and Sichuan Provincial People’s Hospital, Chengdu, Sichuan, China 4 Shenzhen RealOmics (Biotech) Co., Ltd., Shenzhen, China 5 Institute of Endemic Disease, Center for Disease Control and Prevention of Sichuan Province, Chengdu, Sichuan, China 6 The Center of Heart Development, College of Life Sciences, Hunan Norma University, Changsha, China #, These authors contributed equally to this work. *, Authors for correspondence. NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2021.03.12.21253491; this version posted March 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • 9. Atypical Dusps: 19 Phosphatases in Search of a Role
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Digital.CSIC Transworld Research Network 37/661 (2), Fort P.O. Trivandrum-695 023 Kerala, India Emerging Signaling Pathways in Tumor Biology, 2010: 185-208 ISBN: 978-81-7895-477-6 Editor: Pedro A. Lazo 9. Atypical DUSPs: 19 phosphatases in search of a role Yolanda Bayón and Andrés Alonso Instituto de Biología y Genética Molecular, CSIC-Universidad de Valladolid c/ Sanz y Forés s/n, 47003 Valladolid, Spain Abstract. Atypical Dual Specificity Phosphatases (A-DUSPs) are a group of 19 phosphatases poorly characterized. They are included among the Class I Cys-based PTPs and contain the active site motif HCXXGXXR conserved in the Class I PTPs. These enzymes present a phosphatase domain similar to MKPs, but lack any substrate targeting domain similar to the CH2 present in this group. Although most of these phosphatases have no more than 250 amino acids, their size ranges from the 150 residues of the smallest A-DUSP, VHZ/DUSP23, to the 1158 residues of the putative PTP DUSP27. The substrates of this family include MAPK, but, in general terms, it does not look that MAPK are the general substrates for the whole group. In fact, other substrates have been described for some of these phosphatases, like the 5’CAP structure of mRNA, glycogen, or STATs and still the substrates of many A-DUSPs have not been identified. In addition to the PTP domain, most of these enzymes present no additional recognizable domains in their sequence, with the exception of CBM-20 in laforin, GTase in HCE1 and a Zn binding domain in DUSP12.
    [Show full text]
  • Redefining the Specificity of Phosphoinositide-Binding by Human
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.20.163253; this version posted June 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Redefining the specificity of phosphoinositide-binding by human PH domain-containing proteins Nilmani Singh1†, Adriana Reyes-Ordoñez1†, Michael A. Compagnone1, Jesus F. Moreno Castillo1, Benjamin J. Leslie2, Taekjip Ha2,3,4,5, Jie Chen1* 1Department of Cell & Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801; 2Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205; 3Department of Biophysics, Johns Hopkins University, Baltimore, MD 21218; 4Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21205; 5Howard Hughes Medical Institute, Baltimore, MD 21205, USA †These authors contributed equally to this work. *Correspondence: [email protected]. bioRxiv preprint doi: https://doi.org/10.1101/2020.06.20.163253; this version posted June 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. ABSTRACT Pleckstrin homology (PH) domains are presumed to bind phosphoinositides (PIPs), but specific interaction with and regulation by PIPs for most PH domain-containing proteins are unclear. Here we employed a single-molecule pulldown assay to study interactions of lipid vesicles with full-length proteins in mammalian whole cell lysates.
    [Show full text]
  • Mutations of BSND Can Cause Nonsyndromic Deafness Or Bartter Syndrome
    REPORT Molecular Basis of DFNB73: Mutations of BSND Can Cause Nonsyndromic Deafness or Bartter Syndrome Saima Riazuddin,1,2,7 Saima Anwar,3,7 Martin Fischer,4 Zubair M. Ahmed,1,2 Shahid Y. Khan,3 Audrey G.H. Janssen,4 Ahmad U. Zafar,3 Ute Scholl,4 Tayyab Husnain,3 Inna A. Belyantseva,1 Penelope L. Friedman,5 Sheikh Riazuddin,3 Thomas B. Friedman,1 and Christoph Fahlke4,6,* BSND encodes barttin, an accessory subunit of renal and inner ear chloride channels. To date, all mutations of BSND have been shown to cause Bartter syndrome type IV, characterized by significant renal abnormalities and deafness. We identified a BSND mutation (p.I12T) in four kindreds segregating nonsyndromic deafness linked to a 4.04-cM interval on chromosome 1p32.3. The functional consequences of p.I12T differ from BSND mutations that cause renal failure and deafness in Bartter syndrome type IV. p.I12T leaves chloride channel function unaffected and only interferes with chaperone function of barttin in intracellular trafficking. This study provides functional data implicating a hypomorphic allele of BSND as a cause of apparent nonsyndromic deafness. We demonstrate that BSND mutations with different functional consequences are the basis for either syndromic or nonsyndromic deafness. Antenatal Bartter syndrome comprises a genetically and PKDF067, were found to be segregating the c.35T>C allele phenotypically heterogeneous group of salt-losing ne- of BSND resulting in a substitution of threonine for a highly phropathies.1,2 Affected individuals with Bartter syndrome conserved isoleucine (p.I12T) (Figure 2B). In a fourth type IV (MIM 602522) suffer from increased urinary family, PKDF815, 25 affected members enrolled in this chloride excretion, elevated plasma renin activity, hyperal- study.
    [Show full text]